Patron Exim Ltd.
BBSE:PATRON1.80
INR
-0.12
(-6.25%)
ISIN
INE0NPA01011
Return %
Stock
S&P 500
1Y
-67.86
14.20
3Y
-82.00
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Narendrakumar Gangaramdas Patel
- Full Time Employees
- 4
- Sector
- Distribution services
- Industry
- Wholesale distributors
- Address
- A-1106, Empire Business Hub Ahmedabad GU India 380060
- IPO Date
- Mar 6, 2023
- Website
- patronexim.com
- Similar Companies
- Business
- Patron Exim Limited is an India-based trading company specializing in the distribution of pharmaceutical raw materials and industrial chemicals. Its core products include active pharmaceutical ingredients (APIs); excipients; pharmaceutical chemicals and intermediates; solvents; petrochemicals; dyes and pigment chemicals; paints and specialty chemicals; agrochemicals; oil and refinery chemicals; foams and adhesives; plywood and laminates chemicals; as well as chemicals for the food industry, water treatment, resins, plastics, polymers, and various additives. The company offers a diverse product portfolio catering primarily to pharmaceutical, chemical, industrial, and agrochemical sectors. Founded originally in 1982 as a partnership firm named M/s Arvind Traders and headquartered in Ahmedabad, India, Patron Exim transitioned into a private limited company in August 2022 and subsequently converted to a public limited company in December 2022 with a name change to Patron Exim Limited. The company operates both domestically within India and internationally, supplying raw materials primarily to pharmaceutical manufacturers and other industries requiring specialized chemicals. In the past 1-2 years, Patron Exim has undergone significant structural changes including its corporate transformation from a partnership to a public limited company. The company has expanded its product offerings and strengthened its trading and distribution capabilities across a wide range of chemical categories. It maintains a focus on client satisfaction by ensuring timely and committed delivery of products, which supports the company's strategic emphasis on sustaining long-term customer relationships in the pharmaceutical and industrial chemical markets. Patron Exim positions itself with an experienced management team and a broad portfolio of over 150 APIs and chemicals, emphasizing quality service and market adaptability. The company’s strategic initiatives include leveraging its extensive product range to meet diverse industrial needs while pursuing growth through enhanced operational efficiencies and expanded market presence. Overall, Patron Exim Limited operates as a comprehensive trading entity in pharmaceutical raw materials and industrial chemicals with a history of corporate restructuring and business expansion aimed at consolidating its footprint in India and global chemical supply chains. The company continues to innovate and grow its product base while maintaining strong industry relationships through exceptional service delivery and market responsiveness.